- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Ovarian Cancer in Hungary
Total 675 results
-
SandozCompletedB-cell Lymphoma | Cancer | Breast Cancer | Multiple Myeloma | Ovarian Cancer | Lung Cancer | Febrile Neutropenia | Prostate Cancer | Bladder CancerGermany, Italy, Poland, Hungary, Romania, Austria, Belgium, Czech Republic, France, Spain, Switzerland, United Kingdom
-
PfizerTerminatedBreast CancerUnited States, Belgium, Hungary, China, Hong Kong, Poland, Singapore
-
Hoffmann-La RocheCompleted
-
Genzyme, a Sanofi CompanyCompletedCancer | ColorectalKorea, Republic of, Spain, Hungary, Slovakia, Taiwan, France
-
Hoffmann-La RocheCompleted
-
GlaxoSmithKlineCompletedLung Cancer, Small CellBulgaria, Hungary, Russian Federation, Netherlands, Ukraine, United Kingdom
-
Hoffmann-La RocheCompleted
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer | Cancer of the Head and NeckPoland, Germany, Hungary, United Kingdom
-
Eli Lilly and CompanyCompletedBreast CancerBrazil, Greece, Hungary, Peru, Poland, Spain, Venezuela
-
SanofiGenzyme, a Sanofi CompanyCompletedProstate Cancer | Metastatic | Hormone RefractoryBrazil, South Africa, Sweden, Germany, Hungary
-
Bristol-Myers SquibbCompletedBreast CancerAustralia, Hungary, Canada, United Kingdom, Belgium
-
NanobiotixActive, not recruitingHead and Neck CancerFrance, Spain, Hungary, Poland
-
Acrotech Biopharma Inc.CompletedBreast Cancer | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Human Mammary CarcinomaFrance, United States, Czechia, Hungary
-
Eli Lilly and CompanyCompletedBreast CancerAustria, Czech Republic, Hungary, Poland, Romania, Russian Federation
-
European Organisation for Research and Treatment...CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerNetherlands, Spain, United Kingdom, Poland, Belgium, Denmark, Hungary, Germany, Israel, Italy, Austria
-
Nucleix Ltd.Recruiting
-
AstraZenecaCompletedFGFR Inhibition, Pharmacokinetics, Biomarkers | ER+ Breast CancerCzech Republic, Italy, United Kingdom, Hungary, Germany, Romania, Belgium, France
-
AstraZenecaCompleted
-
Spanish Breast Cancer Research GroupPfizer; AstraZenecaCompletedMetastatic Breast CancerSpain, Israel, Hungary, Austria
-
Janssen Pharmaceutica N.V., BelgiumCompletedProstate CancerUnited Kingdom, Belgium, Hungary, Germany
-
Novartis PharmaceuticalsRecruitingMelanoma | Solid Tumor | High Grade Glioma | Non Small Cell Lung Cancer | Rare CancersSpain, Germany, United States, Argentina, Austria, Denmark, France, Hungary, Netherlands, China, Japan, Thailand
-
AstraZenecaCompleted
-
Modra PharmaceuticalsCompletedCastration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States, Germany, Hungary, Poland, Russian Federation, Czechia
-
AstraZenecaCompletedAdvanced Breast Cancer | Metastatic Breast CancerBelgium, Turkey, Canada, Poland, Romania, Hungary, France, Czechia
-
European Organisation for Research and Treatment...Active, not recruitingSalivary Gland CancerBelgium, France, Netherlands, Italy, Hungary, Germany, Austria, Greece
-
Kymab LimitedSanofiActive, not recruitingMelanoma | Renal Cell Carcinoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Pancreatic Cancer | Esophageal Cancer | Metastatic Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Advanced CancerUnited States, Hungary, Italy, Poland, Taiwan, United Kingdom
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
Servier Affaires MédicalesActive, not recruitingMetastatic Colorectal CancerNetherlands, Belgium, Spain, France, Italy, Sweden, Slovenia, Germany, Argentina, Austria, Croatia, Czechia, Greece, Hungary, Ireland, Portugal, Switzerland, United Kingdom
-
PfizerMedivation, Inc.CompletedCancerUnited States, Canada, United Kingdom, France, Poland, Hungary, Germany, Moldova, Republic of, Russian Federation
-
MedSIRHoffmann-La RocheActive, not recruitingEarly Breast CancerSpain, Italy, Germany, Bulgaria, Hungary
-
Ionis Pharmaceuticals, Inc.CompletedNon-small Cell Lung CancerUnited States, Hungary, Poland, Russian Federation
-
ETOP IBCSG Partners FoundationCompletedBreast CancerSpain, Switzerland, Hungary, France, Italy, Peru, Portugal, Sweden
-
SanofiCompletedSmall Cell Lung Cancer | Lung Cancer | Pulmonary NeoplasmsFrance, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Spain, Belgium, Mexico, Argentina, Hungary, United Kingdom, Netherlands
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
Central European Cooperative Oncology GroupCompletedMetastatic Colorectal CancerIsrael, Turkey, Croatia, Portugal, Austria, Bulgaria, Hungary, Romania, Slovakia, Slovenia, Bosnia and Herzegovina, Cyprus, Czech Republic
-
Merck Sharp & Dohme LLCCompletedNon-Small Cell Lung CancerUnited States, Canada, Hungary, Israel, Spain
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Prestige Biopharma LimitedActive, not recruitingLung Cancer | Non-small Cell Lung CancerIndia, Hungary, Georgia, Philippines, Belarus, Bulgaria, Croatia, Greece, Latvia, Malaysia, Poland, Russian Federation, Serbia, Slovakia, Thailand, Turkey, Ukraine
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHungary, Latvia, Turkey
-
PfizerTerminatedAdvanced Breast CancerUnited States, Hungary, Spain, Belgium, China, Hong Kong, Australia, Poland, Canada, India, South Africa
-
Institut de Recherches Internationales ServierBreast International GroupCompletedBreast CancerUnited Kingdom, Italy, France, Belgium, Australia, Canada, Germany, Hungary, Spain
-
Tesaro, Inc.European Organisation for Research and Treatment of Cancer - EORTC; Breast... and other collaboratorsTerminatedOvarian Neoplasms | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Neoplasms, Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Carcinoma of BreastUnited States, Spain, Belgium, Israel, United Kingdom, Italy, Poland, Canada, Hungary, Netherlands, France, Portugal, Greece, Iceland
-
Ferring PharmaceuticalsCompletedProstate CancerBelgium, Germany, Hungary, Netherlands, Romania, Russian Federation, South Africa
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
European Organisation for Research and Treatment...CompletedColorectal CancerBelgium, Germany, Israel, Hungary, Egypt
-
Tanvex BioPharma USA, Inc.CompletedBreast Cancer | Breast Neoplasms | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Early-stage Breast CancerBelarus, Chile, Georgia, Hungary, India, Mexico, Peru, Philippines, Russian Federation, Ukraine
-
Incyte CorporationTerminatedMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, Bulgaria, Hungary, Taiwan, Ukraine
-
Human Genome Sciences Inc.CompletedNon Small Cell Lung CancerUnited States, Germany, Hungary, Romania
-
European Organisation for Research and Treatment...University of GlasgowCompletedKidney CancerBelgium, Netherlands, Austria, Hungary, Italy, Turkey, Israel, United Kingdom
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand